Cortexyme Inc - ESG Rating & Company Profile powered by AI
Alternative companies in the scoring peer group for Cortexyme Inc are displayed below. The report of Cortexyme Inc is assembled by All Street Sevva using advanced artificial intelligence. This ESG assessment for Cortexyme Inc indicates the company's reporting of the United Nations Sustainable Development Goals.
Cortexyme Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.0; made up of an environmental score of 1.3, social score of 2.3 and governance score of 5.3.
3.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1309 | Willow Biosciences Inc | 3.1 | Medium |
| 1309 | biOasis Technologies Inc | 3.1 | Medium |
| 1336 | Cortexyme Inc | 3.0 | Medium |
| 1336 | BridgeBio Pharma Inc | 3.0 | Medium |
| 1336 | Absci Corp | 3.0 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cortexyme Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cortexyme Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cortexyme Inc report the average age of the workforce?
Sign up for free to unlockDoes Cortexyme Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cortexyme Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cortexyme Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cortexyme Inc offer flexible work?
Sign up for free to unlockDoes Cortexyme Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cortexyme Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cortexyme Inc conduct supply chain audits?
Sign up for free to unlockDoes Cortexyme Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cortexyme Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cortexyme Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cortexyme Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cortexyme Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cortexyme Inc disclose water use targets?
Sign up for free to unlockDoes Cortexyme Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cortexyme Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cortexyme Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cortexyme Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cortexyme Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cortexyme Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cortexyme Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cortexyme Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cortexyme Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cortexyme Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cortexyme Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cortexyme Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cortexyme Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cortexyme Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cortexyme Inc disclose its waste policy?
Sign up for free to unlockDoes Cortexyme Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cortexyme Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cortexyme Inc disclose energy use targets?
Sign up for free to unlockDoes Cortexyme Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cortexyme Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cortexyme Inc
These potential risks are based on the size, segment and geographies of the company.
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.